VIM and prostate cancer: For instance, Withaferin-A, a natural bioactive compound, has been shown to induce apoptosis against vimentin-expressing cancer cells [121], while Silibinin can result in the downregulation of vimentin and metalloproteinase-2, thereby reducing prostate cancer cell invasion and motility (Table 1) [124].